Advertisement

Nonviral Delivery of Cancer Genetic Vaccines

  • Steven R. Little
  • Robert LangerEmail author
Chapter
Part of the Advances in Biochemical Engineering/Biotechnology book series (ABE, volume 99)

Abstract

The potential use of genetic vaccines to address numerous diseases including cancer is promising, but currently unrealized. Here, we review advances in the nonviral delivery of antigen-encoded plasmid DNA for the purpose of treating cancer through the human immune system, as this disease has drawn the most attention in this field to date. Brief overviews of dendritic cell immunobiology and the mechanism of immune activation through genetic vaccines set the stage for the desirability of delivery technology. Several promising nonviral delivery techniques are discussed along with a mention of targeting strategies aimed at improving the potency of vaccine formulations. Implications for the future of genetic vaccines are also presented.

Cancer Dendritic cells DNA vaccines Genetic vaccines Nonviral gene delivery 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wolff JA, Malone RW, Williams P, Chong W, Acsadi G et al. (1990) Science 247:1465–1468 Google Scholar
  2. 2.
    Tang DC, De Vit M, Johnston SA (1992) Nature 356:152–154 CrossRefGoogle Scholar
  3. 3.
    Ulmer JB, Donnelly JJ, Parker SE, Rhodes GH, Felgner PL et al. (1993) Science 259:1745–1749 Google Scholar
  4. 4.
    Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC et al. (1993) P Natl Acad Sci USA 90:11478–11482 Google Scholar
  5. 5.
    Johnston SA, Barry MA (1997) Vaccine 15:808–809 CrossRefGoogle Scholar
  6. 6.
    Chambers RS, Johnston SA (2003) Nat Biotechnol 21:1088–1092 CrossRefGoogle Scholar
  7. 7.
    Banchereau J, Steinman RM (1998) Nature 392:245–252 CrossRefGoogle Scholar
  8. 8.
    Bousso P, Robey E (2003) Nat Immunol 4:579–585 CrossRefGoogle Scholar
  9. 9.
    Dallal RM, Lotze MT (2000) Curr Opin Immunol 12:583–588 CrossRefGoogle Scholar
  10. 10.
    Wolff JA, Dowty ME, Jiao S, Repetto G, Berg RK et al. (1992) J Cell Sci 103:1249–1259 Google Scholar
  11. 11.
    Knechtle SJ, Wang J, Jiao S, Geissler EK, Sumimoto R et al. (1994) Transplantation 57:990–996 Google Scholar
  12. 12.
    Nickoloff BJ, Turka LA (1994) Immunol Today 15:464–469 CrossRefGoogle Scholar
  13. 13.
    Warrens AN, Zhang JY, Sidhu S, Watt DJ, Lombardi G et al. (1994) Int Immunol 6:847–853 Google Scholar
  14. 14.
    Kundig TM, Bachmann MF, DiPaolo C, Simard JJ, Battegay M et al. (1995) Science 268:1343–1347 Google Scholar
  15. 15.
    Corr M, Lee DJ, Carson DA, Tighe H (1996) J Exp Med 184:1555–1560 CrossRefGoogle Scholar
  16. 16.
    Ulmer JB, Deck RR, Dewitt CM, Donnhly JI, Liu MA (1996) Immunology 89:59–67 CrossRefGoogle Scholar
  17. 17.
    Doe B, Selby M, Barnett S, Baenziger J, Walker CM (1996) P Natl Acad Sci USA 93:8578–8583 CrossRefGoogle Scholar
  18. 18.
    Iwasaki A, Torres CA, Ohashi PS, Robinson HL, Barber BH (1997) J Immunol 159:11–14 Google Scholar
  19. 19.
    Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr (1996) Nat Med 2:1122–1128 CrossRefGoogle Scholar
  20. 20.
    Casares S, Inaba K, Brumeanu TD, Steinman RM, Bona CA (1997) J Exp Med 186:1481–1486 CrossRefGoogle Scholar
  21. 21.
    Chattergoon MA, Robinson TM, Boyer JD, Weiner DB (1998) J Immunol 160:5707–5718 Google Scholar
  22. 22.
    Porgador A, Irvine KR, Iwasaki A, Barber BH, Restifo NP et al. (1998) J Exp Med 188:1075–1082 CrossRefGoogle Scholar
  23. 23.
    La Cava A, Billetta R, Gaietta G, Bonnin DB, Baird SM et al. (2000) J Immunol 164:1340–1345 Google Scholar
  24. 24.
    Chun S, Daheshia M, Lee S, Eo SK, Rouse BT (1999) J Immunol 163:2393–2402 Google Scholar
  25. 25.
    Timares L, Takashima A, Johnston SA (1998) P Natl Acad Sci USA 95:13147–13152 CrossRefGoogle Scholar
  26. 26.
    Falo LD Jr, Kovacsovics-Bankowski M, Thompson K, Rock KL (1995) Nat Med 1:649–653 CrossRefGoogle Scholar
  27. 27.
    Kovacsovics-Bankowski M, Rock KL (1995) Science 267:243–246 Google Scholar
  28. 28.
    Suto R, Srivastava PK (1995) Science 269:1585–1588 Google Scholar
  29. 29.
    Bennett SR, Carbone FR, Karamalis F, Miller JF, Heath WR (1997) J Exp Med 186:65–70 CrossRefGoogle Scholar
  30. 30.
    Kurts C, Kosaka H, Carbone FR, Miller JF, Heath WR (1997) J Exp Med 186:239–245 Google Scholar
  31. 31.
    Coelho-Castelo AA, Santos Junior RR, Bonato VL, Jamur MC, Oliver C et al. (2003) Hum Gene Ther 14:1279–1285 CrossRefGoogle Scholar
  32. 32.
    Pardoll D (2003) Annu Rev Immunol 21:807–839 CrossRefGoogle Scholar
  33. 33.
    Marincola FM, Jaffee EM, Hicklin DJ, Ferrone S (2000) Adv Immunol 74:181–273 Google Scholar
  34. 34.
    Houghton AN (1994) J Exp Med 180:1–4 CrossRefGoogle Scholar
  35. 35.
    Pardoll DM (2002) Nat Rev Immunol 2:227–238 CrossRefGoogle Scholar
  36. 36.
    Barouch DH, Santra S, Schmitz JE, Kuroda MJ, Fu TM et al. (2000) Science 290:486–492 Google Scholar
  37. 37.
    Le TP, Coonan KM, Hedstrom RC, Charoenvit Y, Sedegah M et al. (2000) Vaccine 18:1893–1901 Google Scholar
  38. 38.
    Felgner PL (2003) Methods 31:181–182 CrossRefGoogle Scholar
  39. 39.
    Manthorpe M, Cornefert-Jensen F, Hartikka J, Felgner J, Rundell A et al. (1993) Hum Gene Ther 4:419–431 Google Scholar
  40. 40.
    Winegar RA, Monforte JA, Suing KD, O'Loughlin KG, Rudd CJ et al. (1996) Hum Gene Ther 7:2185–2194 Google Scholar
  41. 41.
    Jiao S, Williams P, Berg RK, Hodgeman BA, Liu L et al. (1992) Hum Gene Ther 3:21–33 Google Scholar
  42. 42.
    Williams RS, Johnston SA, Riedy M, DeVit MJ, McElligott SG et al. (1991) P Natl Acad Sci USA 88:2726–2730 Google Scholar
  43. 43.
    Pertmer TM, Eisenbraun MD, McCabe D, Prayaga SK, Fuller DH et al. (1995) Vaccine 13:1427–1430 Google Scholar
  44. 44.
    Bergstresser PR, Fletcher CR, Streilein JW (1980) J Invest Dermatol 74:77–80 CrossRefGoogle Scholar
  45. 45.
    Tuettenberg A, Jonuleit H, Tuting T, Bruck J, Knop J et al. (2003) Gene Ther 10:243–250 Google Scholar
  46. 46.
    Dietrich G, Spreng S, Favre D, Viret JF, Guzman CA (2003) Curr Opin Mol Ther 5:10–19 Google Scholar
  47. 47.
    Vicat JM, Boisseau S, Jourdes P, Laine M, Wion D et al. (2000) Hum Gene Ther 11:909–916 Google Scholar
  48. 48.
    Mendiratta SK, Thai G, Eslahi NK, Thull NM, Matar M et al. (2001) Cancer Res 61:859–863 Google Scholar
  49. 49.
    Lohr F, Lo DY, Zaharoff DA, Hu K, Zhang X et al. (2001) Cancer Res 61:3281–4 Google Scholar
  50. 50.
    Kalat M, Kupcu Z, Schuller S, Zalusky D, Zehetner M et al. (2002) Cancer Res 62:5489–5494 Google Scholar
  51. 51.
    Paster W, Zehetner M, Kalat M, Schuller S, Schweighoffer T (2003) Gene Ther 10:717–724 Google Scholar
  52. 52.
    Babiuk S, Baca-Estrada ME, Foldvari M, Storms M, Rabussay D et al. (2002) Vaccine 20:3399–3408 Google Scholar
  53. 53.
    Rodriguez-Cuevas S, Barroso-Bravo S, Almanza-Estrada J, Cristobal-Martinez L, Gonzalez-Rodriguez E (2001) Arch Med Res 32:273–276 CrossRefGoogle Scholar
  54. 54.
    Zabner J (1997) Adv Drug Deliver Rev 27:17–28 Google Scholar
  55. 55.
    Xu Y, Szoka FC Jr (1996) Biochemistry 35:5616–5623 Google Scholar
  56. 56.
    Gregoriadis G, Saffie R, de Souza JB (1997) FEBS Lett 402:107–110 CrossRefGoogle Scholar
  57. 57.
    Perrie Y, Frederik PM, Gregoriadis G (2001) Vaccine 19:3301–3310 CrossRefGoogle Scholar
  58. 58.
    Perrie Y, Obrenovic M, McCarthy D, Gregoriadis G (2002) J Lipos Res 12:185–197 Google Scholar
  59. 59.
    Okamoto T, Kaneda Y, Yuzuki D, Huang SK, Chi DD et al. (1997) Gene Ther 4:969–976 Google Scholar
  60. 60.
    Zhou WZ, Kaneda Y, Huang S, Morishita R, Hoon D (1999) Gene Ther 6:1768–1773 Google Scholar
  61. 61.
    Tanaka M, Kaneda Y, Fujii S, Yamano T, Hashimoto K et al. (2002) Mol Ther 5:291–299 Google Scholar
  62. 62.
    Correale P, Cusi MG, Sabatino M, Micheli L, Pozzessere D et al. (2001) Eur J Cancer 37:2097–2103 Google Scholar
  63. 63.
    Jones DH, Corris S, McDonald S, Clegg JC, Farrar GH (1997) Vaccine 15:814–817 CrossRefGoogle Scholar
  64. 64.
    Kempf M, Mandal B, Jilek S, Thiele L, Voros J et al. (2003) J Drug Target 11:11–18 Google Scholar
  65. 65.
    O'Hagan DT, Singh M, Gupta RK (1998) Adv Drug Deliver Rev 32:225–246 Google Scholar
  66. 66.
    Randolph GJ, Inaba K, Robbiani DF, Steinman RM, Muller WA (1999) Immunity 11:753–761 CrossRefGoogle Scholar
  67. 67.
    Thiele L, Rothen-Rutishauser B, Jilek S, Wunderli-Allenspach H, Merkle HP et al. (2001) J Control Release 76:59–71 Google Scholar
  68. 68.
    Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S et al. (2000) Nature 408:740–745 Google Scholar
  69. 69.
    Frazza EJ, Schmitt EE (1971) J Biomed Mater Res 5:43–58 CrossRefGoogle Scholar
  70. 70.
    Woodland JH, Yolles S (1973) J Med Chem 16:897–901 CrossRefGoogle Scholar
  71. 71.
    Beck LR, Cowsar DR, Lewis DH, Gibson JW, Flowers CE (1979) Am J Obstet Gynecol 135:419–426 Google Scholar
  72. 72.
    Sinclair RG (1973) Environ Sci Technol 7:955–956 CrossRefGoogle Scholar
  73. 73.
    Rokkanen P, Bostman O, Vainionpaa S, Vihtonen K, Tormala P et al. (1985) Lancet 1:1422–1424 Google Scholar
  74. 74.
    Bercovy M, Goutallier D, Voisin MC, Geiger D, Blanquaert D et al. (1985) Clin Orthop Relat R 196:159–168 Google Scholar
  75. 75.
    Williams DF, Mort E (1977) J Bioeng 1:231–238 Google Scholar
  76. 76.
    Langer R, Cleland JL, Hanes J (1997) Adv Drug Deliver Rev 28:97–119 Google Scholar
  77. 77.
    Odonnell PB, McGinity JW (1997) Adv Drug Deliver Rev 28:25–42 Google Scholar
  78. 78.
    Gander B, Wehrli E, Alder R, Merkle HP (1995) J Microencapsul 12:83–97 Google Scholar
  79. 79.
    Wang D, Robinson DR, Kwon GS, Samuel J (1999) J Control Release 57:9–18 Google Scholar
  80. 80.
    Walter E, Moelling K, Pavlovic J, Merkle HP (1999) J Control Release 61:361–374 Google Scholar
  81. 81.
    Hedley ML, Curley J, Urban R (1998) Nat Med 4:365–368 CrossRefGoogle Scholar
  82. 82.
    Klencke B, Matijevic M, Urban RG, Lathey JL, Hedley ML et al. (2002) Clin Cancer Res 8:1028–1037 Google Scholar
  83. 83.
    Sheets EE, Urban RG, Crum CP, Hedley ML, Politch JA et al. (2003) Am J Obstet Gynecol 188:916–926 Google Scholar
  84. 84.
    Chen SC, Jones DH, Fynan EF, Farrar GH, Clegg JC et al. (1998) J Virol 72:5757–5761 Google Scholar
  85. 85.
    Fu K, Pack DW, Klibanov AM, Langer R (2000) Pharmaceut Res 17:100–106 CrossRefGoogle Scholar
  86. 86.
    Shenderova A, Burke TG, Schwendeman SP (1999) Pharmaceut Res 16:241–248 CrossRefGoogle Scholar
  87. 87.
    Walter E, Dreher D, Kok M, Thiele L, Kiama SG et al. (2001) J Control Release 76:149–168 Google Scholar
  88. 88.
    Garg S, Oran A, Wajchman J, Sasaki S, Maris CH et al. (2003) Nat Immunol 4:907–912 Google Scholar
  89. 89.
    McKeever U, Barman S, Hao T, Chambers P, Song S et al. (2002) Vaccine 20:1524–1531 Google Scholar
  90. 90.
    Ando S, Putnam D, Pack DW, Langer R (1999) J Pharm Sci 88:126–130 CrossRefGoogle Scholar
  91. 91.
    Singh M, Briones M, Ott G, O'Hagan D (2000) P Natl Acad Sci USA 97:811–816 Google Scholar
  92. 92.
    Denis-Mize KS, Dupuis M, MacKichan ML, Singh M, Doe B et al. (2000) Gene Ther 7:2105–2112 Google Scholar
  93. 93.
    Denis-Mize KS, Dupuis M, Singh M, Woo C, Ugozzoli M et al. (2003) Cell Immunol 225:12–20 Google Scholar
  94. 94.
    O'Hagan D, Singh M, Ugozzoli M, Wild C, Barnett S et al. (2001) J Virol 75:9037–9043 Google Scholar
  95. 95.
    Luo YP, O'Hagan D, Zhou H, Singh M, Ulmer J et al. (2003) Vaccine 21:1938–1947 Google Scholar
  96. 96.
    Cui Z, Mumper RJ (2002) Bioconjug Chem 13:1319–1327 CrossRefGoogle Scholar
  97. 97.
    Cui Z, Mumper RJ (2002) J Control Release 81:173–184 Google Scholar
  98. 98.
    Cui Z, Mumper RJ (2002) Pharmaceut Res 19:939–946 Google Scholar
  99. 99.
    Cui Z, Mumper RJ (2002) J Pharm Pharmacol 54:1195–1203 CrossRefGoogle Scholar
  100. 100.
    Cui Z, Baizer L, Mumper RJ (2003) J Biotechnol 102:105–115 CrossRefGoogle Scholar
  101. 101.
    Kumar M (2000) React Funct Polym 46:1–27 Google Scholar
  102. 102.
    Stahl PD (1992) Curr Opin Immunol 4:49–52 CrossRefGoogle Scholar
  103. 103.
    Roy K, Mao HQ, Huang SK, Leong KW (1999) Nat Med 5:387–391 Google Scholar
  104. 104.
    Cui Z, Mumper RJ (2001) J Control Release 75:409–419 Google Scholar
  105. 105.
    Kabbaj M, Phillips NC (2001) J Drug Target 9:317–328 Google Scholar
  106. 106.
    Wang C, Ge Q, Ting D, Nguyen D, Shen HR et al. (2004) Nat Mater 3:190–196 Google Scholar
  107. 107.
    Little SR, Lynn DM, Ge Q, Anderson DG, Puram SV et al. (2004) P Natl Acad Sci USA 101:9534–9539 Google Scholar
  108. 108.
    Lynn DM, Anderson DG, Putnam D, Langer R (2001) J Am Chem Soc 123:8155–8156 Google Scholar
  109. 109.
    Lynn DM, Amiji MM, Langer R (2001) Angew Chem Int Edit 40:1707–1710 CrossRefGoogle Scholar
  110. 110.
    Boussif O, Lezoualch F, Zanta MA, Mergny MD, Scherman D et al. (1995) P Natl Acad Sci USA 92:7297–7301 Google Scholar
  111. 111.
    Fields RC, Shimizu K, Mule JJ (1998) P Natl Acad Sci USA 95:9482–9487 Google Scholar
  112. 112.
    Alters SE, Gadea JR, Sorich M, O'Donoghue G, Talib S et al. (1998) J Immunother 21:17–26 Google Scholar
  113. 113.
    Tjandrawan T, Martin DM, Maeurer MJ, Castelli C, Lotze MT et al. (1998) J Immunother 21:149–157 Google Scholar
  114. 114.
    Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT, Falo LD Jr (1996) J Exp Med 183:283–287 CrossRefGoogle Scholar
  115. 115.
    Amoscato AA, Prenovitz DA, Lotze MT (1998) J Immunol 161:4023–4032 Google Scholar
  116. 116.
    Gong J, Chen D, Kashiwaba M, Kufe D (1997) Nat Med 3:558–561 CrossRefGoogle Scholar
  117. 117.
    Siders WM, Vergilis KL, Johnson C, Shields J, Kaplan JM (2003) Mol Ther 7:498–505 CrossRefGoogle Scholar
  118. 118.
    Diebold SS, Lehrmann H, Kursa M, Wagner E, Cotten M et al. (1999) Hum Gene Ther 10:775–786 Google Scholar
  119. 119.
    Irvine AS, Trinder PK, Laughton DL, Ketteringham H, McDermott RH et al. (2000) Nat Biotechnol 18:1273–1278 Google Scholar
  120. 120.
    Walter E, Merkle HP (2002) J Drug Target 10:11–21 CrossRefGoogle Scholar
  121. 121.
    Walter E, Thiele L, Merkle HP (2001) STP Pharma Sci 11:45–56 Google Scholar
  122. 122.
    Arthur JF, Butterfield LH, Roth MD, Bui LA, Kiertscher SM et al. (1997) Cancer Gene Ther 4:17–25 Google Scholar
  123. 123.
    Chamarthy SP, Kovacs JR, McClelland E, Gattens D, Meng WS (2003) Mol Immunol 40:483–490 CrossRefGoogle Scholar
  124. 124.
    Strobel I, Berchtold S, Gotze A, Schulze U, Schuler G et al. (2000) Gene Ther 7:2028–2035 Google Scholar
  125. 125.
    Boczkowski D, Nair SK, Nam JH, Lyerly HK, Gilboa E (2000) Cancer Res 60:1028–1034 Google Scholar
  126. 126.
    Milazzo C, Reichardt VL, Muller MR, Grunebach F, Brossart P (2003) Blood 101:977–982 CrossRefGoogle Scholar
  127. 127.
    Muller MR, Grunebach F, Nencioni A, Brossart P (2003) J Immunol 170:5892–5896 Google Scholar
  128. 128.
    Nencioni A, Muller MR, Grunebach F, Garuti A, Mingari MC et al. (2003) Cancer Gene Ther 10:209–214 Google Scholar
  129. 129.
    Heiser A, Maurice MA, Yancey DR, Coleman DM, Dahm P et al. (2001) Cancer Res 61:3388–3393 Google Scholar
  130. 130.
    Su Z, Dannull J, Heiser A, Yancey D, Pruitt S et al. (2003) Cancer Res 63:2127–2133 Google Scholar
  131. 131.
    Muller MR, Tsakou G, Grunebach F, Schmidt SM, Brossart P (2004) Blood 103:1763–1769 CrossRefGoogle Scholar
  132. 132.
    Zhao Y, Boczkowski D, Nair SK, Gilboa E (2003) Blood 102:4137–4142 CrossRefGoogle Scholar
  133. 133.
    Regnault A, Lankar D, Lacabanne V, Rodriguez A, Thery C et al. (1999) J Exp Med 189:371–380 CrossRefGoogle Scholar
  134. 134.
    Kim JJ, Yang JS, Dang K, Manson KH, Weiner DB (2001) Clin Cancer Res 7:882s–889s Google Scholar
  135. 135.
    Biragyn A, Tani K, Grimm MC, Weeks S, Kwak LW (1999) Nat Biotechnol 17:253–258 Google Scholar
  136. 136.
    Albert ML, Pearce SF, Francisco LM, Sauter B, Roy P et al. (1998) J Exp Med 188:1359–1368 CrossRefGoogle Scholar
  137. 137.
    Jiang W, Swiggard WJ, Heufler C, Peng M, Mirza A et al. (1995) Nature 375:151–155 CrossRefGoogle Scholar
  138. 138.
    Cui Z, Hsu CH, Mumper RJ (2003) Drug Dev Ind Pharm 29:689–700 Google Scholar
  139. 139.
    Rodriguez F, Harkins S, Redwine JM, de Pereda JM, Whitton JL (2001) J Virol 75:10421–10430 Google Scholar
  140. 140.
    Rodriguez F, An LL, Harkins S, Zhang J, Yokoyama M et al. (1998) J Virol 72:5174–5181 Google Scholar
  141. 141.
    Rodriguez F, Zhang J, Whitton JL (1997) J Virol 71:8497–8503 Google Scholar
  142. 142.
    Delogu G, Howard A, Collins FM, Morris SL (2000) Infect Immun 68:3097–3102 CrossRefGoogle Scholar
  143. 143.
    Tobery T, Siliciano RF (1999) J Immunol 162:639–642 Google Scholar
  144. 144.
    Fu TM, Guan L, Friedman A, Ulmer JB, Liu MA et al. (1998) Vaccine 16:p1711–1717 CrossRefGoogle Scholar
  145. 145.
    Sadasivan B, Lehner PJ, Ortmann B, Spies T, Cresswell P (1996) Immunity 5:103–114 CrossRefGoogle Scholar
  146. 146.
    Spee P, Neefjes J (1997) Eur J Immunol 27:2441–2449 Google Scholar
  147. 147.
    Pike SE, Yao L, Jones KD, Cherney B, Appella E et al. (1998) J Exp Med 188:2349–2356 CrossRefGoogle Scholar
  148. 148.
    Pike SE, Yao L, Setsuda J, Jones KD, Cherney B et al. (1999) Blood 94:2461–2468 Google Scholar
  149. 149.
    Cheng WF, Hung CF, Chai CY, Hsu KF, He L et al. (2001) J Clin Invest 108:669–678 CrossRefGoogle Scholar
  150. 150.
    Rowell JF, Ruff AL, Guarnieri FG, Staveley-O'Carroll K, Lin X et al. (1995) J Immunol 155:1818–1828 Google Scholar
  151. 151.
    Ji H, Wang TL, Chen CH, Pai SI, Hung CF et al. (1999) Hum Gene Ther 10:2727–2740 CrossRefGoogle Scholar
  152. 152.
    Wu TC, Guarnieri FG, Staveley-O'Carroll KF, Viscidi RP, Levitsky HI et al. (1995) P Natl Acad Sci USA 92:11671–11675 Google Scholar
  153. 153.
    Rodriguez F, Harkins S, Redwine JM, de Pereda JM, Whitton JL (2001) J Virol 75:10421–10430 Google Scholar
  154. 154.
    Forns X, Emerson SU, Tobin GJ, Mushahwar IK, Purcell RH et al. (1999) Vaccine 17:1992–2002 CrossRefGoogle Scholar
  155. 155.
    Geissler M, Bruss V, Michalak S, Hockenjos B, Ortmann D et al. (1999) J Virol 73:4284–4292 Google Scholar
  156. 156.
    Rice J, King CA, Spellerberg MB, Fairweather N, Stevenson FK (1999) Vaccine 17:3030–3038 CrossRefGoogle Scholar
  157. 157.
    Steinman RM, Hawiger D, Nussenzweig MC (2003) Annu Rev Immunol 21:685–711 CrossRefGoogle Scholar
  158. 158.
    Morita A, Ariizumi K, Ritter R 3rd, Jester JV, Kumamoto T et al. (2001) Gene Ther 8:1729–1737 Google Scholar
  159. 159.
    Ross R, Sudowe S, Beisner J, Ross XL, Ludwig-Portugall I et al. (2003) Gene Ther 10:1035–1040 Google Scholar
  160. 160.
    Sudowe S, Ludwig-Portugall I, Montermann E, Ross R, Reske-Kunz AB (2003) Mol Ther 8:567–575 CrossRefGoogle Scholar
  161. 161.
    Schlesinger S, Dubensky TW (1999) Curr Opin Biotechnol 10:434–439 CrossRefGoogle Scholar
  162. 162.
    Wang B, Merva M, Dang K, Ugen KE, Boyer J et al. (1994) AIDS Res Hum Retrov 10:S35–41 CrossRefGoogle Scholar
  163. 163.
    Little SR, Lynn DM, Puram SV, Langer R (2005) J Con Rel 107(3):449–462 Google Scholar

Authors and Affiliations

  1. 1.Department of Chemical Engineering and Center for Cancer ResearchMassachusetts Institute of TechnologyCambridgeUSA

Personalised recommendations